55542-26-2

Basic information

• Product Name: 17beta-hydroxy-17-(3-hydroxy-1-propynyl)androst-4-ene-3-one
• Synonyms: 17beta-hydroxy-17-(3-hydroxy-1-propynyl)androst-4-ene-3-one;17β-Hydroxy-17-(3-hydroxy-1-propynyl)androst-4-en-3-one
• CAS NO: 55542-26-2
• Molecular Formula: C₂₂H₃₀O₃
• Molecular Weight: 342.4718
• EINECS: 259-700-1
• Mol File: 55542-26-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Water Solubility: 102mg/L at 20℃
• CAS DataBase Reference: 17beta-hydroxy-17-(3-hydroxy-1-propynyl)androst-4-ene-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 17beta-hydroxy-17-(3-hydroxy-1-propynyl)androst-4-ene-3-one(55542-26-2)
• EPA Substance Registry System: 17beta-hydroxy-17-(3-hydroxy-1-propynyl)androst-4-ene-3-one(55542-26-2)

Safety Data

• Hazardous Substances Data: 55542-26-2(Hazardous Substances Data)

Usage

Type of Compound

Synthetic chemical compound

Classification

Androgen and anabolic steroid derivatives

Parent Compound

Testosterone

Usage

Performance-enhancing drug

User Groups

Athletes and bodybuilders

Purpose

Increase muscle mass and strength

Competitive Sports

Usage banned due to potential for abuse and adverse health effects

Regulation

Strictly regulated and monitored by healthcare professionals

Health Risks

Potential for misuse and adverse health effects

Upstream product

• 96584-49-5 21,24-dinor-17βH-chol-5-en-20-yne-3β,17,23-triol 
• 63-05-8 Androstenedione 
• 107-19-7 propargyl alcohol 
• 853-23-6 prasterone acetate 
• 108-94-1 cyclohexanone 
• 555-31-7 aluminum isopropoxide 
• 108-88-3 toluene 
• 6089-04-9 3-(tetrahydropyran-2'-yloxy)propyne 
• 972-46-3 3-ethoxyandrosta-3,5-dien-17-one 

Downstream Products

• 55542-27-3 17α-(3-hydroxypropyl)-17β-hydroxy-4-androsten-3-one 
• 976-70-5 3-oxopregn-4-ene-21,17α-carbolactone 
• 976-71-6 canrenone 

Relevant articles and documents

Having a method for the synthesis of intermediates spirondactone

The invention relates to a synthesis method of a chemical medicine, and concretely relates to a synthesis method of a spironolactone intermediate canrenone. The method comprises the following steps: carrying out an ethynylation reaction on a compound I 4-androstenedione (4AD), hydrogenating, carrying out an oxidation cyclization reaction, and carrying out a bromization and debromination reaction to obtain the compound V canrenone, and the above reaction route is shown in the specification. A synthesis method of the structure of an important 21,17-carboxy lactone spiro ring adopted in the invention is different from previous process modes, and is concise and efficient. The method has the characteristics of high yield, good selectivity, low cost, mild reactions, suitableness for industrialization, stability and easy realization.